AU2002224122A1 - Method of screening remedy for diabetes - Google Patents

Method of screening remedy for diabetes

Info

Publication number
AU2002224122A1
AU2002224122A1 AU2002224122A AU2412202A AU2002224122A1 AU 2002224122 A1 AU2002224122 A1 AU 2002224122A1 AU 2002224122 A AU2002224122 A AU 2002224122A AU 2412202 A AU2412202 A AU 2412202A AU 2002224122 A1 AU2002224122 A1 AU 2002224122A1
Authority
AU
Australia
Prior art keywords
diabetes
remedy
screening
screening remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224122A
Inventor
Nozomi Katayama
Hideaki Tojo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2002224122A1 publication Critical patent/AU2002224122A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002224122A 2000-11-29 2001-11-28 Method of screening remedy for diabetes Abandoned AU2002224122A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000363187 2000-11-29
JP2000-363187 2000-11-29
PCT/JP2001/010386 WO2002044367A1 (en) 2000-11-29 2001-11-28 Method of screening remedy for diabetes

Publications (1)

Publication Number Publication Date
AU2002224122A1 true AU2002224122A1 (en) 2002-06-11

Family

ID=18834335

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224122A Abandoned AU2002224122A1 (en) 2000-11-29 2001-11-28 Method of screening remedy for diabetes

Country Status (2)

Country Link
AU (1) AU2002224122A1 (en)
WO (1) WO2002044367A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19813835A1 (en) * 1998-03-20 1999-09-23 Metagen Gesellschaft Fuer Genomforschung Mbh Human nucleic acid sequences and protein products from normal breast tissue, useful for breast cancer therapy
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
WO2000055200A1 (en) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. 50 human secreted proteins
EP1241256A4 (en) * 1999-12-20 2004-07-14 Takeda Chemical Industries Ltd Novel gene and use thereof

Also Published As

Publication number Publication date
WO2002044367A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
EP1469316A2 (en) Screening method
AU2001267978A1 (en) Method for analyzing words
AU2002249467A1 (en) Screening method
AU2003242340A1 (en) Novel screening method
AU2002247215A1 (en) Method for screening compounds
AU1553101A (en) Screening method
AU6429000A (en) Screening method
AU2001230365A1 (en) Method of screening compounds for biological activity
AUPS337802A0 (en) Method of screening for antidiabetic agents
AU2002224122A1 (en) Method of screening remedy for diabetes
AU2003227268A1 (en) Novel screening method
AU4856501A (en) Screening method for compounds
AU2872501A (en) Screening method
AU2002354247A1 (en) Screening method
AU2001278729A1 (en) Method of screening remedy for heart failure
AU2003264441A1 (en) Method of screening remedy for proliferative disease
AU2003242342A1 (en) Novel screening method
AU2000224577A1 (en) Screening method
AU2002354206A1 (en) Method of screening drug
AU2509201A (en) Screening method for compounds capable of modularing egr-1-regulated expression
AU2002335165A1 (en) Method of examining type i diabetes
AU2001288116A1 (en) Screening method
AU2002220868A1 (en) Screening method
AUPQ646600A0 (en) A method of screening
AU2002308626A1 (en) Method for screening microcrystallizations for crystal formation